Furthermore, we performed GSEA to explain, from the perspective of transcriptomics, the immunotherapy-specific responses of ROS1 mutation versus wild-type using the RNA sequencing data of the TCGA melanoma dataset (Figure 4A and Supplementary Table 1). Here, ROS1 is linked to melanoma.